Loading…
Loading…
NBSE (NeuBase Therapeutics, Inc.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
| ASLN | ASLAN Pharmaceuticals Limited | $0.60 | $777.1M |
| VBIV | VBI Vaccines Inc. | $0.07 | $1.9M |
| ONCT | Oncternal Therapeutics, Inc. | $0.53 | $1.6M |
| SAVAW | Cassava Sciences, Inc. Warrant | $0.03 | $1.4M |
| CWBR | CohBar, Inc. | $0.41 | $1.2M |
| TMBR | Timber Pharmaceuticals, Inc. | $0.34 | $1.2M |
| CYTO | Altamira Therapeutics Ltd. | $0.30 | $1.1M |
| IMPL | Impel Pharmaceuticals Inc. | $0.04 | $956.0K |
| NMTRQ | 9 Meters Biopharma, Inc. | $0.00 | $1.4K |
| ONCSQ | OncoSec Medical Incorporated | $0.00 | $60.0 |